Code | 3095B | ||||||||||
MA number | 68/0398/14-S | ||||||||||
Product Form: | tbl plg 90x50 mg (blis.PVC/PVDC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 19.02.2015 |
Pediatric warnings: | Yes |
SPC: | SPC_Quetiapine Accord 50mg tbl plg_09_2024.pdf |
PIL: | PIL_Quetiapine Accord 50,200,300,400mg tbl plg_09_2024.pdf |
Dokument: | Quetiapine Accord_Prirucka pre zdravotnickych pracovnikov.pdf |
Safety feature | Yes |
Data update: | 24.08.2022 |